Robert C Frederich (Robert Frederich)

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 6

Top Topics

Cardiovascular Risk Factors

Top Venues

Diabetes therapy : research, treatment and education of diabetes and related disorders

European heart journal

Diabetes, obesity & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Joseph M Kim, Deepak L Bhatt, Samuel Dagogo-Jack, David Z I Cherney, Francesco Cosentino, Darren K McGuire, Richard E Pratley, Chih-Chin Liu, Nilo B Cater, Robert C Frederich, James P Mancuso, Christopher P Cannon
Potential for residual cardiovascular risk reduction: Eligibility for icosapent ethyl in the VERTIS CV population with type 2 diabetes and atherosclerotic cardiovascular disease. Diabetes, obesity & metabolism (2023)
Linong Ji, Jie Liu, Zhi Jin Xu, Zhiqi Wei, Ruya Zhang, Seema Malkani, Nilo B Cater, Robert C Frederich
Efficacy and Safety of Ertugliflozin Added to Metformin: A Pooled Population from Asia with Type 2 Diabetes and Overweight or Obesity. Diabetes therapy : research, treatment and education of diabetes and related disorders (2023)
Ambarish Pandey, Ahmed A Kolkailah, Francesco Cosentino, Christopher P Cannon, Robert C Frederich, David Z I Cherney, Samuel Dagogo-Jack, Richard E Pratley, Nilo B Cater, Ira Gantz, James P Mancuso, Darren K McGuire
Ertugliflozin and hospitalization for heart failure across the spectrum of pre-trial ejection fraction: post-hoc analyses of the VERTIS CV trial. European heart journal (2023)
Linong Ji, Jie Liu, Zhi Jin Xu, Zhiqi Wei, Ruya Zhang, Seema Malkani, Nilo B Cater, Robert C Frederich
Efficacy and Safety of Ertugliflozin Added to Metformin: A Pooled Population from Asia with Type 2 Diabetes and Overweight or Obesity. Diabetes therapy : research, treatment and education of diabetes and related disorders 14 (2) (2023)
Linong Ji, Jie Liu, Zhi Jin Xu, Zhiqi Wei, Ruya Zhang, Seema Malkani, Nilo B Cater, Robert C Frederich
Efficacy and Safety of Ertugliflozin Added to Metformin: A Pooled Population from Asia with Type 2 Diabetes and Overweight or Obesity. Diabetes therapy : research, treatment and education of diabetes and related disorders 14 (2) (2023)
Linong Ji, Jie Liu, Zhi Jin Xu, Zhiqi Wei, Ruya Zhang, Seema Malkani, Nilo B Cater, Robert C Frederich
Efficacy and Safety of Ertugliflozin Added to Metformin: A Pooled Population from Asia with Type 2 Diabetes and Overweight or Obesity. Diabetes therapy : research, treatment and education of diabetes and related disorders 14 (2) (2023)